GenomeWeb explores key findings from GHTC’s report Innovation for a changing world: The role of US leadership in global health R&D, quoting GHTC Director Kaitlin Christenson and GHTC Policy Officer Ashley Bennett.
Key policy recommendations from GHTC’s report Innovation for a changing world: The role of US leadership in global health R&D are highlighted in an article in FierceBiotechResearch, including the need for sustained funding for global health R&D and stronger roles for the US Agency for International Development and US Food and Drug Administration in advancing development of and access to new global health products.
GHTC’s press release on the launch of its report Innovation for a changing world: The role of US leadership in global health R&D was picked up by Science Codex. The article highlights key findings from the report and policy recommendations for the US government, particularly the need for sustained funding and a strategic, coordinated approach to global health R&D. The article notes that recent budget cuts at the US National Institutes of Health—the largest funder of global health R&D—could jeopardize future progress against HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases.
Voice of America reports on GHTC’s report Innovation for a changing world: The role of US leadership in global health R&D, highlighting key findings and the report’s recommendations for US policymakers. GHTC Director Kaitlin Christenson is quoted, discussing the importance of sustained, reliable funding for global health R&D.